Pandox (PNDX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
15 Jul, 2026Executive summary
Strong like-for-like growth in Q4 2025, driven by robust business demand, event calendar, and leisure travel, with acquisitions—especially Dalata—boosting portfolio quality, value, and international exposure.
Dalata acquisition completed in November 2025, adding 31+1 properties in Ireland and the UK, resulting in an acquisition gain of SEK 1.6 billion and an EPRA NAV uplift of SEK 3.4 billion.
Group revenues increased by 9% and net operating income by 22% in Q4, with cash earnings up 23% year-on-year after adjusting for one-time costs.
Board proposes a 6% dividend increase to SEK 4.50 per share, reflecting confidence in ongoing cash generation.
Profit for the period rose to MSEK 3,174 (1,706), with EPS at SEK 16.13 (9.04), including a one-time acquisition result from Dalata.
Financial highlights
Q4 revenue grew 9% year-over-year (5% like-for-like), with total NOI up 22% (7% like-for-like); Dalata contributed MSEK 146 in revenue and MSEK 138 in NOI for Q4.
Adjusted cash earnings reached SEK 666 million in Q4, a 23% increase year-on-year; adjusted cash earnings per share SEK 11.34.
EBITDA for Q4 was MSEK 999, down 2% year-over-year; full-year EBITDA up 3% to MSEK 4,086.
Unrealized property value changes for the year were positive SEK 117 million, but currency effects reduced property values by SEK 4.6 billion.
Market value of properties increased to MSEK 91,743 (76,334), up 20%.
Outlook and guidance
Expectation of continued hotel market resilience in 2026, with demand supported by macroeconomic improvements and a benign supply outlook.
Dalata properties anticipated to contribute substantially to NOI and cash earnings in 2026.
RevPAR growth for 2026 projected at 2%-4% overall, with strongest outlook in the Nordics and Germany.
Q1 2026 expected to follow normal seasonal patterns, with promising business on the books.
First quarter of 2026 expected to be seasonally weaker, but business on the books is stronger than the previous year.
Latest events from Pandox
- Q2 2026 saw 15% revenue and 25% NOI growth, led by Leases and Dalata, with stable demand.PNDX
Q2 202616 Jul 2026 - Strong Q2 growth in revenue, profit, and cash flow, with a positive outlook for hotel demand.PNDX
Q2 202415 Jul 2026 - European hotel market shows resilience and growth, driven by steady demand and innovation.PNDX
Hotel Market Day 20248 Jul 2026 - Active ownership, growth investments, and sustainability drive robust value creation and resilience.PNDX
CMD 202611 May 2026 - Strong Q1 growth in revenue and NOI, driven by acquisitions and resilient market demand.PNDX
Q1 202629 Apr 2026 - Q3 saw strong LFL growth, major UK acquisitions, and a SEK 2bn share issue despite profit pressure.PNDX
Q3 202418 Jan 2026 - Revenue and net operating income increased, led by leases and acquisitions, with stable outlook.PNDX
Q1 202529 Dec 2025 - Profitable growth, portfolio expansion, and a positive 2025 outlook amid strong hotel demand.PNDX
Q4 202420 Dec 2025 - Q3 2025 saw strong growth, with Dalata acquisition to drive further gains in 2026.PNDX
Q3 202523 Oct 2025